| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cb0cca3e0d65e98f45fb77cf3a64239 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate |
2007-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08a818eef0735059f50be64c42de5739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6ea2e2b0f684359de93af422aa865b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abf10a233246aaffca5a58cd19a6a3f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c24df3cc4c28dbb364e907753416fa1 |
| publicationDate |
2013-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2487938-C2 |
| titleOfInvention |
NUCLEIC ACID OF FORMULA (I): GlXmGn OR (II): GlXmGn, DESIGNED TO BE USED FIRST OF ALL AS IMMUNOGEN/ADJUVANT |
| abstract |
FIELD: biotechnologies. n SUBSTANCE: single-thread RNA is described with common formula G 1 X m G n or C 1 X m C n , which is modified with lipid. The single-thread RNA may act as immunogen, inducing the inherent immune response. The pharmaceutical composition is described. The invention may be used to treat infectitious diseases, allergies or cancer diseases. n EFFECT: improved composition properties. n 22 cl, 15 dwg, 24 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2636003-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221418-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9719093-B2 |
| priorityDate |
2006-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |